Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
28 Sep 2014 ESMO 2014 Press Release: Significant Presence of Women in Oncology, but Still Under-Representation in Leadership Positions, Greek Survey Shows Bioethics, legal and economic issues
28 Sep 2014 Metastatic NSCLC: New Findings, New Avenues to Explore Lung and other thoracic tumours
28 Sep 2014 Pathway of the Day: Hedgehog Pathology/Molecular biology
28 Sep 2014 ESMO 2014: Second-Line Targeted Treatments in Patients with Advanced Hepatocellular Carcinoma Gastrointestinal cancers - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: Adding Cediranib to Chemotherapy Improves Progression-Free Survival for Metastatic or Recurrent Cervical Cancer, Phase II Trial Shows Gynaecologic malignancies - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: Pertuzumab Adds 16 Months Survival Benefit to Trastuzumab and Chemotherapy Treatment for HER2-Positive Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: IMPRESS Trial Data on Continuing Tyrosine Kinase Inhibitor Therapy After Resistance Development in Lung Cancer Reported Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014 Press Commentary: Phase III Trials Presented at ESMO 2014 Report Major Advances in Supportive Care for Cancer Patients Palliative and supportive care
27 Sep 2014 ESMO 2014: How to Guide the Selection of Chemotherapy Regimen for Non-Squamous Non-Small Cell Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014: Results of LUX-Lung 8, the Largest Prospective Trial to Compare EGFR TKIs in Patients with Relapsed/Refractory Squamous Cell Carcinoma of the Lung Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014 Press Release: Customising Chemotherapy in Lung Cancer: New Phase II Data Reported in Two Late-Breaking Studies Translational research - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014 Press Release: Docetaxel or Pemetrexed in Addition to Cisplatin Achieve Comparable Outcomes in Non-Squamous Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014: Rolapitant Plus Granisetron/Dexamethasone in Prevention of Chemotherapy-Induced Nausea and Vomiting Palliative and supportive care
27 Sep 2014 ESMO 2014 Press Release: Immune Checkpoint Inhibitors Provide Antitumour Activity Across Malignant Diseases Immuno-oncology
27 Sep 2014 ESMO 2014: Afatinib vs Methotrexate in Second-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Head and neck cancers - Anticancer agents & Biologic therapy